ANTABIO

ANTABIO

ANTABIO

Antabio is a private biopharmaceutical company developing novel antibacterial resistancebreakers to treat drugresistant infections in areas of highest unmet medical need.
Raised
$14.7M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
€12,500,000
Venture capital (Series A) - 2018
Omnes Capital Galia Gestion BNP Paribas Développement +1
Team Size
1–10
Employees
Location
Headquarters
€12,500,000 Venture capital (Series A)
FinSMEs

Biopharma Company Antabio Raises Additional €5.2M; Closes €12.5M Series A

Health Funding